Australia - English - Department of Health (Therapeutic Goods Administration)

leo pharma pty ltd - methylprednisolone aceponate, quantity: 1 mg/g - ointment - excipient ingredients: liquid paraffin; microcrystalline wax; white soft paraffin; hydrogenated castor oil - topical treatment of eczema and psoriasis.

Australia - English - Department of Health (Therapeutic Goods Administration)

leo pharma pty ltd - methylprednisolone aceponate, quantity: 1 mg/g - ointment - excipient ingredients: white soft paraffin; liquid paraffin; white beeswax; purified water; dicocoyl pentaerythrityl distearyl citrate; sorbitan sesquioleate; aluminium stearate - topical treatment of eczema and psoriasis. indications as at 7 december 2001. topical eczema and psoriasis.

Australia - English - Department of Health (Therapeutic Goods Administration)

leo pharma pty ltd - methylprednisolone aceponate, quantity: 1 mg/g - cream - excipient ingredients: butylated hydroxytoluene; purified water; hard fat; cetostearyl alcohol; glyceryl monostearate; glycerol; disodium edetate; peg-40 stearate; benzyl alcohol; decyl oleate; medium chain triglycerides - topical treatment of eczema and psoriasis.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - methylprednisolone sodium succinate -

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - methylprednisolone sodium succinate -

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - methylprednisolone aceponate, quantity: 1 mg/g - ointment - excipient ingredients: white soft paraffin; microcrystalline wax; liquid paraffin; hydrogenated castor oil - tanilone fatty ointment is indicated for the topical treatment of eczema and psoriasis in adults and children.

Australia - English - Department of Health (Therapeutic Goods Administration)

leo pharma pty ltd - methylprednisolone aceponate, quantity: 0.1 % - lotion - excipient ingredients: steareth-21; benzyl alcohol; glycerol; purified water; disodium edetate; steareth-2; medium chain triglycerides - for the topical treatment of eczema in children and adults. indications as at 7 december 2001. topical treatment for eczema and psoriasis in adults and children.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - methylprednisolone sodium succinate -

Israel - English - Ministry of Health

genmedix , israel - methylprednisolone as hemisuccinate - lyophilized powder for solution for injection or infusion - methylprednisolone as hemisuccinate 1 g/vial - methylprednisolone - methylprednisolone - methylprednisolone mylan is indicated to treat any condition in which iv corticosteroid treatment is required such as: endocrine disorders, rheumatic disorders, collagen diseases, immune complex diseases, dermatologic diseases, allergic states, ophthalmic diseases, gastrointestinal diseases, respiratory diseases, hematologic disorders, management of neoplastic diseases, edematous states, nervous system disorders and organ transplantation.

Israel - English - Ministry of Health

genmedix , israel - methylprednisolone as hemisuccinate - lyophilized powder for solution for injection or infusion - methylprednisolone as hemisuccinate 500 mg/vial - methylprednisolone - methylprednisolone - methylprednisolone mylan is indicated to treat any condition in which iv corticosteroid treatment is required such as: endocrine disorders, rheumatic disorders, collagen diseases, immune complex diseases, dermatologic diseases, allergic states, ophthalmic diseases, gastrointestinal diseases, respiratory diseases, hematologic disorders, management of neoplastic diseases, edematous states, nervous system disorders and organ transplantation